ES2144204T3 - Derivados de fullereno como eliminadores de radicales libres. - Google Patents

Derivados de fullereno como eliminadores de radicales libres.

Info

Publication number
ES2144204T3
ES2144204T3 ES96302581T ES96302581T ES2144204T3 ES 2144204 T3 ES2144204 T3 ES 2144204T3 ES 96302581 T ES96302581 T ES 96302581T ES 96302581 T ES96302581 T ES 96302581T ES 2144204 T3 ES2144204 T3 ES 2144204T3
Authority
ES
Spain
Prior art keywords
sub
derivatives
free radicals
fullereno
eliminators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96302581T
Other languages
English (en)
Inventor
Long Y Chiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2144204T3 publication Critical patent/ES2144204T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B32/00—Carbon; Compounds thereof
    • C01B32/15—Nano-sized carbon materials
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B32/00—Carbon; Compounds thereof
    • C01B32/15—Nano-sized carbon materials
    • C01B32/152—Fullerenes
    • C01B32/156—After-treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/06—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
    • C07C309/09—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/19—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/44—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed ring system having more than three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2604/00—Fullerenes, e.g. C60 buckminsterfullerene or C70
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/734—Fullerenes, i.e. graphene-based structures, such as nanohorns, nanococoons, nanoscrolls or fullerene-like structures, e.g. WS2 or MoS2 chalcogenide nanotubes, planar C3N4, etc.
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/734—Fullerenes, i.e. graphene-based structures, such as nanohorns, nanococoons, nanoscrolls or fullerene-like structures, e.g. WS2 or MoS2 chalcogenide nanotubes, planar C3N4, etc.
    • Y10S977/735—Carbon buckyball
    • Y10S977/737—Carbon buckyball having a modified surface
    • Y10S977/738—Modified with biological, organic, or hydrocarbon material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/84—Manufacture, treatment, or detection of nanostructure
    • Y10S977/895—Manufacture, treatment, or detection of nanostructure having step or means utilizing chemical property
    • Y10S977/896—Chemical synthesis, e.g. chemical bonding or breaking
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Composite Materials (AREA)
  • Manufacturing & Machinery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Silicon Polymers (AREA)
  • Cosmetics (AREA)
  • Polyethers (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE RELACIONA CON DERIVADOS DE FULERENO, QUE SON CAPACES DE CAPTURAR RADICALES LIBRES. DICHOS DERIVADOS TIENEN LA FORMULA F(-X){SUB,M}(-Y-Z){SUB,N}, EN DONDE F ES UN NUCLEO DE FULERENO; CADA X ES, INDEPENDIENTEMENTE, -CO{SUB,2}{SUP,-}, -SO{SUB,3}{SUP,-}, -SH, O SIMILARES; CADA -Y-Z- ES, INDEPENDIENTEMENTE, (ALQUIL ETER C{SUB,3-30}){SUB,50}-CH{SUB,2}CO{SUB,2}{SUP,-}, (ALQUIL ESTER C{SUB,3-30}){SUB,50}-CH{SUB,2}SO{SUB,3}{SUP,-}, (ALQUIL AMIDA C{SUB,3-30}){SUB,50}-CH{SUB,2}SH, O SIMILARES; M ES 0-30; N ES 0-30; Y LA SUMA DE M Y N ES 230.
ES96302581T 1995-10-26 1996-04-12 Derivados de fullereno como eliminadores de radicales libres. Expired - Lifetime ES2144204T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/547,714 US5648523A (en) 1995-10-26 1995-10-26 Fullerene derivatives as free-radical scavengers

Publications (1)

Publication Number Publication Date
ES2144204T3 true ES2144204T3 (es) 2000-06-01

Family

ID=24185835

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96302581T Expired - Lifetime ES2144204T3 (es) 1995-10-26 1996-04-12 Derivados de fullereno como eliminadores de radicales libres.

Country Status (5)

Country Link
US (2) US5648523A (es)
EP (1) EP0770577B1 (es)
JP (1) JPH09136964A (es)
DE (1) DE69607437T2 (es)
ES (1) ES2144204T3 (es)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US6380434B1 (en) 1995-10-26 2002-04-30 Long Y. Chiang Fullerene derivatives
US6455709B1 (en) 1995-10-26 2002-09-24 Long Y. Chiang E-isomeric fullerene derivatives
US6949660B2 (en) * 1995-10-26 2005-09-27 Seth Nanotechnology, Incorporated Chiral (1pyrrolino) fullerene derivatives
US6046361A (en) * 1995-10-26 2000-04-04 Chiang; Long Y. Polyorganofullerenes
US6265443B1 (en) * 1996-06-03 2001-07-24 Washington University Method for treating neuronal injury with carboxyfullerene
WO1998050152A1 (en) * 1997-05-07 1998-11-12 Olah George A Nanoscale solid superacid catalysts with pendant fluoroalkylsulfonic acid or fluoro, perfluoroalkylsulfonic acid groups
WO1999023097A1 (en) 1997-11-03 1999-05-14 Duke University Substituted porphyrins
DE69839157T2 (de) * 1997-12-19 2009-05-14 Cordis Corp., Miami Lakes Fullurene enthaltendes katherdersystem
AU752456B2 (en) 1998-02-09 2002-09-19 Rousseau Research, Inc. Tobacco products with Vitamin E
US6082370A (en) * 1998-02-09 2000-07-04 Rousseau Research, Inc. Cigarette with dry powered Vitamin E
ATE295345T1 (de) * 1998-03-10 2005-05-15 Fujisawa Pharmaceutical Co Fullerenverbindungen
ATE312103T1 (de) 1999-01-25 2005-12-15 Nat Jewish Med & Res Center Substituierte porphyrine und deren therapeutische verwendungen
DE19903385A1 (de) * 1999-01-29 2000-08-03 Max Delbrueck Centrum Mittel zur Prävention von In-Stent Restenosen und postoperativen Entzündungen
RU2164918C1 (ru) * 1999-08-31 2001-04-10 Институт нефтехимии и катализа АН РБ и УНЦ РАН Способ получения 3,4-фуллерен[60]-1,2-окситиоэтан-2-(1',4'-бут-2'-ен)-2-оксида
US6355225B1 (en) * 1999-10-05 2002-03-12 Wm. Marsh Rice University Tda Research, Inc. Fullerene contrast agent for magnetic resonance imaging and spectroscopy
RU2165424C1 (ru) * 1999-12-31 2001-04-20 Институт нефтехимии и катализа АН РБ и УНЦ РАН Способ получения 3,4-фуллерен [60]-1,2-окситиоэтан-2(2'-метил-1',4'-бут-2'-ен)-2-оксида
RU2165425C1 (ru) * 1999-12-31 2001-04-20 Институт нефтехимии и катализа АН РБ и УНЦ РАН Способ получения 3,4-фуллерен [60]-1,2-окситиоэтан-2(2',3'-диметил-1',4'-бут-2'-ен)-2-оксида
TWI250874B (en) * 2000-03-24 2006-03-11 Nat Health Research Institutes Pharmaceutical compositions for preventing or treating disorders associated with bacterial or viral infection
US20030069281A1 (en) * 2000-06-14 2003-04-10 Irwin Fridovich Tetrapyrroles
US6397102B1 (en) * 2000-07-06 2002-05-28 Ceramoptec Industries, Inc. Device and method for photoactivated drug therapy
WO2002024273A1 (en) * 2000-09-21 2002-03-28 Chiang Long Y Tumor treatment
JP4848585B2 (ja) 2000-12-25 2011-12-28 ソニー株式会社 フラーレン誘導体の製造方法及びそのフラーレン誘導体、プロトン伝導体、並びに電気化学デバイス
DE60233317D1 (de) 2001-01-19 2009-09-24 Nat Jewish Med & Res Center Medikament zum schutz in der radiotherapie
RU2227120C2 (ru) * 2001-02-05 2004-04-20 Плугин Александр Илларионович Технология производства фуллеренсодержащих материалов
US6452037B1 (en) * 2001-04-23 2002-09-17 Long Y. Chiang Multioligonanilinated fullerenes
US20040038946A1 (en) * 2001-04-27 2004-02-26 Wilson Lon J. Fullerene-based drugs targeted to bone
RU2191183C1 (ru) * 2001-05-14 2002-10-20 Институт нефтехимии и катализа АН РБ и УНЦ РАН СПОСОБ ПОЛУЧЕНИЯ 2,3-ФУЛЛЕРЕНО[60]-6-МЕТИЛ-2,3,4,7-ТЕТРАГИДРО-1H-1λ6-ТИЕПИН-1,1-ДИОКСИДА
RU2191182C1 (ru) * 2001-05-14 2002-10-20 Институт нефтехимии и катализа АН РБ и УНЦ РАН СПОСОБ ПОЛУЧЕНИЯ 2,3-ФУЛЛЕРЕНО[60]-2,3,4,7-ТЕТРАГИДРО-1H λ6-ТИЕПИН-1,1-ДИОКСИДА
EP1439842A4 (en) * 2001-06-01 2009-09-02 Nat Jewish Med & Res Center OXIDANT CAPTAIN FOR THE TREATMENT OF DIABETES OR FOR THE USE IN THE TRANSPLANTATION OR INDUCTION OF IMMUNOTOLERANE
DE10130937C1 (de) * 2001-06-27 2003-01-30 Fraunhofer Ges Forschung Verfahren und Vorrichtung zur Ermittlung der Raumgeometrie eines gebogenen Strangprofils
US7812190B2 (en) * 2001-10-01 2010-10-12 Tda Research, Inc. Derivatization and solubilization of fullerenes for use in therapeutic and diagnostic applications
AU2002334784A1 (en) 2001-10-01 2003-04-14 Tda Research, Inc. Derivatization and solubilization of insoluble classes of fullerenes
RU2210537C2 (ru) * 2001-10-16 2003-08-20 Плугин Александр Илларионович Технология производства фуллеренсодержащих веществ
US7145032B2 (en) * 2002-02-23 2006-12-05 Washington University Therapeutic malonic acid/acetic acid C60 tri-adducts of buckminsterfullerene and methods related thereto
US20030162837A1 (en) * 2002-02-23 2003-08-28 Dugan Laura L. Carboxyfullerenes and methods of use thereof
US7485721B2 (en) * 2002-06-07 2009-02-03 Duke University Substituted porphyrins
US7810380B2 (en) 2003-03-25 2010-10-12 Tearlab Research, Inc. Systems and methods for collecting tear film and measuring tear film osmolarity
US8020433B2 (en) * 2003-03-25 2011-09-20 Tearlab Research, Inc. Systems and methods for a sample fluid collection device
AU2003251307A1 (en) * 2002-09-10 2004-04-30 The Trustees Of The University Pennsylvania Carbon nanotubes: high solids dispersions and nematic gels thereof
AU2003272899A1 (en) * 2002-10-04 2004-04-23 Mitsubishi Chemical Corporation Additive to negative electrode material for lithium secondary battery, negative electrode material for lithium secondary battery and, using the negative electrode material for lithium secondary battery, negative electrode and lithium secondary battery
US7879260B2 (en) * 2002-10-04 2011-02-01 Mitsubishi Chemical Corporation Additive for anode material for lithium secondary battery, anode material for lithium secondary battery, anode and lithium secondary battery using the anode material for lithium secondary battery
ATE529094T1 (de) * 2003-01-27 2011-11-15 Vitamin C60 Biores Corp Zusammensetzung zur äusseren anwendung
WO2004080453A1 (ja) * 2003-03-10 2004-09-23 Mitsubishi Corporation 抗ｃ型肝炎ウイルス剤と抗ｈｉｖ剤
JP2006524245A (ja) * 2003-04-10 2006-10-26 シー スィクスティ、インコーポレイテッド 皮膚病学的症状を改善するためのフラーレン組成物
US20050058675A1 (en) * 2003-04-10 2005-03-17 Wilson Stephen R. Fullerene compositions for ameliorating dermatological conditions
TW200512007A (en) * 2003-05-30 2005-04-01 Fullerene Internat Corp Cosmetic compositions containing fullerene clusters
RU2236852C1 (ru) * 2003-06-23 2004-09-27 Закрытое акционерное общество "ДЕСКО" Средство для ингибирования репродукции оболоченных вирусов, способ его получения, фармацевтическая композиция и способ ингибирования вирусных инфекций
US7025840B1 (en) 2003-07-15 2006-04-11 Lockheed Martin Corporation Explosive/energetic fullerenes
US7641882B2 (en) * 2003-09-30 2010-01-05 Massachusetts Institute Of Technology Fullerenic structures and such structures tethered to carbon materials
US20060040938A1 (en) * 2003-10-10 2006-02-23 Uwe Hartnagel Substituted fullerene compositions and their use as antioxidants
US20050288236A1 (en) * 2003-10-10 2005-12-29 Russ Lebovitz Substituted fullerene formulations and their use in ameliorating oxidative stress diseases or inhibiting cell death
US7163956B2 (en) * 2003-10-10 2007-01-16 C Sixty Inc. Substituted fullerene compositions and their use as antioxidants
US20060247152A1 (en) * 2005-05-02 2006-11-02 Russ Lebovitz Substituted fullerenes and their use as inhibitors of cell death
WO2005040755A2 (en) * 2003-10-20 2005-05-06 The Regents Of The University Of California Nanoscale transduction systems for detecting molecular interactions
JP2007513977A (ja) * 2003-12-15 2007-05-31 ナノ−シー，インク． ラジカル・スカベンジャーとして有用な高フラーレン
US20050220862A1 (en) * 2004-03-31 2005-10-06 Bernstein Joel E Compositions with reduced hepatotoxicity
RU2006138234A (ru) * 2004-03-31 2008-05-10 Ниппон Каяку Кабусики Кайся (Jp) Новый водорастворимый фуллерен, способ его получения и генератор активного кислорода, содержащий фуллерен
WO2005105214A1 (en) * 2004-05-04 2005-11-10 Universite Paris Sud Compositions comprising water-insoluble fullerenes and their use for preventing damages caused by free radicals
WO2006028635A2 (en) * 2004-09-02 2006-03-16 C Sixty Inc. Fullerene compositions for ameliorating hearing loss, collateral damage of chemotherapy, or mucositis
US20060112858A1 (en) * 2004-11-12 2006-06-01 Saigon Hi Tech Park Liquid nano carbon and application products
EP1657294A1 (de) * 2004-11-16 2006-05-17 Symrise GmbH & Co. KG Antiallergene Riechstoffzubereitungen
JP2006160664A (ja) * 2004-12-07 2006-06-22 Vitamin C60 Bioresearch Kk フリーラジカル疾患予防治療用組成物
WO2006078257A1 (en) * 2005-01-19 2006-07-27 C Sixty Inc. Substituted fullerene compositions and their use in treatment of shock
WO2007081353A2 (en) * 2005-02-25 2007-07-19 The Regents Of The University Of California Hydro cyano and cyano fullerene derivatives
US7588824B2 (en) * 2005-02-25 2009-09-15 The Regents Of The University Of California Hydrogen cyano fullerene containing proton conducting membranes
US20070003807A1 (en) * 2005-02-25 2007-01-04 Fred Wudl Fullerene containing composite membranes
US20080015268A1 (en) * 2005-02-25 2008-01-17 The Regents Of The University Of California Hydrogen cyano fullerene containing proton conducting membranes
US7794682B1 (en) 2005-02-28 2010-09-14 Tda Research, Inc. Methods for fullerene recovery
JP5051768B2 (ja) * 2005-03-23 2012-10-17 学校法人 聖マリアンナ医科大学 運動器疾患の治療・予防用医薬組成物
US20100219385A1 (en) * 2005-04-04 2010-09-02 Carbon Labs, Inc. Fusion fuel container and reactant spin-enhancement
WO2007084161A2 (en) * 2005-04-04 2007-07-26 Carbon Labs, Inc. Fusion fuel containers and system
WO2006116021A2 (en) * 2005-04-22 2006-11-02 Intematix Corporation Mri technique based on electron spin resonance and endohedral contrast agent
CN100366529C (zh) * 2005-06-20 2008-02-06 中国科学院理化技术研究所 多硝基的富勒烯基含能材料的合成方法
CN1739562A (zh) * 2005-09-19 2006-03-01 中国科学院高能物理研究所 金属富勒醇在抑制肿瘤生长中的应用
US20080020977A1 (en) * 2005-11-21 2008-01-24 Russ Lebovitz Use of Fullerenes to Oxidize Reduced Redox Proteins
US8048275B2 (en) * 2006-01-20 2011-11-01 Kyushu University, National University Corporation Method of solubilizing carbon nanomaterial
US7947262B2 (en) * 2006-09-26 2011-05-24 Virginia Commonwealth University Use of fullerenes for the treatment of mast cell and basophil-mediated disease
PL2101574T3 (pl) 2006-11-29 2017-01-31 Solenne Bv Związki i formulacje odpowiednie do wymiatania rodników
JP2010511720A (ja) * 2006-12-05 2010-04-15 ユニバーシティー オブ フロリダ リサーチ ファウンデイション インコーポレイテッド 官能化フラーレンの放射線誘導性の加熱または点火に基づくシステムおよび方法
EP2125022A4 (en) * 2007-02-02 2012-08-08 Dvb Global Llc ACCORDING TO GOLDEN CENTER HARMONIZED WATER AND AQUEOUS SOLUTIONS
AU2008317422A1 (en) * 2007-10-22 2009-04-30 Luna Innovations Incorporated Metallofullerene contrast agents
US20110190251A1 (en) * 2008-03-03 2011-08-04 Kepley Christopher L Method for inhibiting the build-up of arterial plaque by administering fullerenes
CN102105146A (zh) 2008-05-23 2011-06-22 国立犹太保健医院 用于治疗与暴露于烷化物质有关的损伤的方法
WO2010056621A2 (en) 2008-11-12 2010-05-20 University Of Florida Research Foundation, Inc. Devices for thermally induced transformations controlled by irradiation of functionalized fullerenes
US9314027B2 (en) * 2009-04-02 2016-04-19 University Of Florida Research Foundation, Inc. Functionalized fullerenes as antifungal agents
US8614366B2 (en) * 2009-09-06 2013-12-24 Stephen R. Wilson Methods for genetic plant transformation using water-soluble fullerene derivatives
WO2011127285A2 (en) 2010-04-08 2011-10-13 University Of Florida Research Foundation, Inc. Functionalized fullerenes as a biomass stimulant and a life extension agent
WO2012099855A2 (en) * 2011-01-17 2012-07-26 Marelle, Llc Water-soluble functionalized fullerenes
WO2012116017A2 (en) * 2011-02-24 2012-08-30 Rieke Metals Inc. Polythiophene–fullerene conjugates for photovoltaic cells
RU2472496C2 (ru) * 2011-03-15 2013-01-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский Институт гриппа" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "НИИ гриппа" Минздравсоцразвития России) Применение фуллеренолов с60(oh)18-24 и с60(oh)30-38 в качестве противовирусных препаратов
TN2011000327A1 (en) 2011-06-30 2012-12-17 Fathi Moussa Fullerene and its use to maintain good health and to prolong the expected lifespan of mammals
RU2484812C1 (ru) * 2012-03-29 2013-06-20 Учреждение Российской академии наук Институт высокомолекулярных соединений РАН Способ получения сорбента на основе неорганических пористых гранул и полигидроксифуллерена для удаления атерогенных липопротеинов из плазмы крови
US20160331698A1 (en) * 2014-01-13 2016-11-17 University Of Central Florida Research Foundation, Inc. Fullerene compounds as antioxidant therapy
JP2015218127A (ja) * 2014-05-15 2015-12-07 昭和電工株式会社 ポリ水酸化フラーレンの製造方法
BR112017005121A2 (pt) 2014-09-23 2018-07-31 Tearlab Res Inc sistemas e métodos para integração de coleta de lágrima microfluídica e análise de fluxo lateral de analitos de interesse.
CN107913289A (zh) * 2016-10-08 2018-04-17 北京福纳康生物技术有限公司 水溶性富勒烯结构在制备治疗肿瘤的药物中的应用
CN108201540A (zh) * 2016-12-19 2018-06-26 北京福纳康生物技术有限公司 富勒烯结构在制备治疗白血病的药物中的应用
TWI704127B (zh) * 2017-03-16 2020-09-11 國立臺灣大學 富勒烯衍生物及其用途
CN108853142A (zh) * 2017-05-09 2018-11-23 北京福纳康生物技术有限公司 水溶性富勒烯纳米颗粒在制备抑制肿瘤生长药物中的应用
EP3724158A4 (en) * 2017-12-14 2022-01-26 Buckyol Limited ANISOTROPIC NANOPARTICLE COMPOSITIONS AND METHODS
KR20200010806A (ko) 2018-07-23 2020-01-31 삼성전자주식회사 연마 슬러리 및 그 제조 방법과 반도체 소자의 제조 방법
CN110876757B (zh) * 2018-09-05 2021-11-16 中国科学院化学研究所 富勒烯结构在制备治疗动脉粥样硬化的药物中的应用
US20210378982A1 (en) * 2018-09-24 2021-12-09 The Cleveland Clinic Foundation Fullerenes to treat diseases and conditions
US12570665B2 (en) 2019-06-10 2026-03-10 University Of Massachusetts Compositions comprising fullerenyl mesochlorin nano-photosensitizers with covalently bound antibiotics and their uses in combination therapy
US20230248766A1 (en) * 2019-11-15 2023-08-10 Redox Balance, Llc Methods of treating oxidative stress to modulate redox balance, preventing oxidative stress induced cell damage and death
US12576108B2 (en) 2019-12-02 2026-03-17 Fieldpoint (Cyprus) Limited Compositions comprising hyper harmonized hydroxyl modified fullerene substances
CN118895045B (zh) * 2024-10-08 2025-02-07 广州富思德新材料科技有限公司 一种用于太阳能光伏发电边框及支架的聚氨酯复合材料

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177248A (en) * 1991-10-28 1993-01-05 Exxon Research And Engineering Company Process of forming polysubstituted fullerenes
DE4338672A1 (de) * 1993-11-12 1995-08-17 Hoechst Ag Amino-ureido- und thioureido-fulleren-Derivate und Verfahren zu deren Herstellung
US5811460A (en) * 1994-01-24 1998-09-22 The Regents Of The University Of California Water soluble fullerenes with antiviral activity

Also Published As

Publication number Publication date
JPH09136964A (ja) 1997-05-27
DE69607437D1 (de) 2000-05-04
US5648523A (en) 1997-07-15
EP0770577A1 (en) 1997-05-02
DE69607437T2 (de) 2000-08-10
EP0770577B1 (en) 2000-03-29
US5994410A (en) 1999-11-30

Similar Documents

Publication Publication Date Title
ES2144204T3 (es) Derivados de fullereno como eliminadores de radicales libres.
DK0846704T3 (da) Højfermenterbar resistent stivelse
DK0841928T3 (da) Sustained release-formulering af d-threo-methylphenidat
DE59811817D1 (de) Koronarer Stent
BR9909325A (pt) Composições de poliuretano não elastomérico
ATE249466T1 (de) Silizium enthaltender kettenverlängerer
MX9204661A (es) Compuestos intermedios derivados de eter y procedimiento para su preparacion.
FR2734002B1 (fr) Assemblage d'une bande fibreuse supportee
AR245494A1 (es) Una composicion detergente.
DE69615857D1 (de) Latente härterzusammensetzungen und verfahren für ihre herstellung
ES2055424T3 (es) Derivados de n-fenilbenzamida con actividad anti-ulcera y anti-alergia y un metodo para su preparacion.
CY1106444T1 (el) 17b-νιτρο-11β-αρυλοστepοειδη και παραγωγα αυτων ως ορμονικοι αγωνιστες ή ανταγωνιστες
TR199701576T1 (xx) N-aril-1,2,4,-triazolin-5-onlar.
ITRM920380A1 (it) Apparecchio d'ispezione di rocche di filo.
NO20024626D0 (no) Kabeltape og fremgangsmåte til fremstilling av samme
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
ES2192610T3 (es) Aminouracilos substituidos.
GR1000664B (el) Παρασκευη ενωσεων αντι-υπερχοληστερολαιμικης τετραζολης και ενδιαμεσων αυτων.
NO994254L (no) Fremgangsmaate for fjerning av faste asfaltrester produsert i petroleumsindustrien
EP0806950A4 (en) METHOD FOR INHIBITING ENVIRONMENTALLY DRUGS
ES2128112T3 (es) Nuevas composiciones herbicidas.
AR014119A1 (es) Utilizacion de cetolidas para la fabricacion de composiciones farmaceuticas destinadas a prevenir complicaciones tromboticas arteriales asociadas a laaterosclerosis
BR0007807A (pt) Hìbridos interespecìficos de nicotiana e sua progênie
NO964429L (no) Flammeretarderende sammensetninger
ES2059055T3 (es) Quitaesmalte de uñas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 770577

Country of ref document: ES